Ayala Pharmaceuticals Inc (fka ADXS)

[DewDiligence]

The number of authorized shares is shown on the balance sheet (among other places) in the latest 10-K report:

https://www.sec.gov/Archives/edgar/data/1100397/000149315217014889/form10-k.htm#a_026

Common stock - $0.001 par value; 65,000,000 shares authorized, 41,206,538 shares issued and outstanding at October 31, 2017

Preferred stock, $0.001 par value; 5,000,000 shares authorized; Series B Preferred Stock; 0 shares issued and outstanding at October 31, 2017

The 41,206,538 figure for common shares outstanding on 10/31/17 excludes 8,349,612 options, warrants, and RSUs that have not yet vested (see page F-10). Thus, as of 10/31/17, ADXS had 49.5M fully-diluted shares, which is 15.5M fewer shares than the (existing) 65M authorization limit.